These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 38508132)

  • 21. Neoadjuvant Treatment for Pancreatic Cancer.
    Raufi AG; Manji GA; Chabot JA; Bates SE
    Semin Oncol; 2019 Feb; 46(1):19-27. PubMed ID: 30630600
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Total neoadjuvant FOLFIRINOX versus neoadjuvant gemcitabine-based chemoradiotherapy and adjuvant gemcitabine for resectable and borderline resectable pancreatic cancer (PREOPANC-2 trial): study protocol for a nationwide multicenter randomized controlled trial.
    Janssen QP; van Dam JL; Bonsing BA; Bos H; Bosscha KP; Coene PPLO; van Eijck CHJ; de Hingh IHJT; Karsten TM; van der Kolk MB; Patijn GA; Liem MSL; van Santvoort HC; Loosveld OJL; de Vos-Geelen J; Zonderhuis BM; Homs MYV; van Tienhoven G; Besselink MG; Wilmink JW; Groot Koerkamp B;
    BMC Cancer; 2021 Mar; 21(1):300. PubMed ID: 33757440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Neoadjuvant therapy versus upfront surgery for borderline-resectable pancreatic cancer.
    Han S; Choi SH; Choi DW; Heo JS; Han IW; Park DJ; Ryu Y
    Minerva Chir; 2020 Feb; 75(1):15-24. PubMed ID: 31115240
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neoadjuvant therapy for pancreatic cancer: Limitations and advances of response assessment (Review).
    Xu J; Zhan H; Li F; Hu S; Wang L
    Oncol Rep; 2021 Apr; 45(4):. PubMed ID: 33649823
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Adjuvant therapy for pancreatic cancer: to treat or not to treat?
    Berlin JD
    Oncology (Williston Park); 2007 May; 21(6):712-8; discussion 720, 725-6, 730. PubMed ID: 17564327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Management of borderline and locally advanced pancreatic cancer: where do we stand?
    He J; Page AJ; Weiss M; Wolfgang CL; Herman JM; Pawlik TM
    World J Gastroenterol; 2014 Mar; 20(9):2255-66. PubMed ID: 24605025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adjuvant and neoadjuvant therapies in resectable pancreatic cancer: a systematic review of randomized controlled trials.
    D'Angelo FA; Antolino L; La Rocca M; Petrucciani N; Magistri P; Aurello P; Ramacciato G
    Med Oncol; 2016 Mar; 33(3):28. PubMed ID: 26883935
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Novel Considerations in Surgical Management of Individuals with Pancreatic Adenocarcinoma.
    Barnes CA; Tsai S
    Hematol Oncol Clin North Am; 2022 Oct; 36(5):979-994. PubMed ID: 36265994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. ASO Author Reflections: Total Neoadjuvant Therapy with Chemotherapy Alone for Pancreatic Cancer?
    Miller PN; Nakakura EK
    Ann Surg Oncol; 2024 Sep; 31(9):6203-6204. PubMed ID: 38909112
    [No Abstract]   [Full Text] [Related]  

  • 30. Development of chemotherapy and significance of conversion surgery after chemotherapy in unresectable pancreatic cancer.
    Furuse J; Shibahara J; Sugiyama M
    J Hepatobiliary Pancreat Sci; 2018 May; 25(5):261-268. PubMed ID: 29651809
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Neoadjuvant therapy for resectable pancreatic cancer.
    Raut CP; Evans DB; Crane CH; Pisters PW; Wolff RA
    Surg Oncol Clin N Am; 2004 Oct; 13(4):639-61, ix. PubMed ID: 15350939
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neoadjuvant strategies for pancreatic cancer.
    Evans DB; Wolff RA; Crane CH
    Oncology (Williston Park); 2001 Jun; 15(6):727-37; discussion 741-4, 747. PubMed ID: 11430206
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Localized Pancreatic Cancer: Multidisciplinary Management.
    Coveler AL; Herman JM; Simeone DM; Chiorean EG
    Am Soc Clin Oncol Educ Book; 2016; 35():e217-26. PubMed ID: 27249726
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Status of neoadjuvant therapy for resectable pancreatic cancer.
    Hoffman JP
    Surg Oncol Clin N Am; 2010 Apr; 19(2):411-8. PubMed ID: 20159522
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Current consensus and controversy in neoadjuvant therapy for pancreatic cancer].
    Ou ZL; Li YX; Ji LD; Ke MJ
    Zhonghua Wai Ke Za Zhi; 2020 Feb; 58(2):99-104. PubMed ID: 32074807
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Does neoadjuvant treatment in resectable pancreatic cancer improve overall survival? A systematic review and meta-analysis of randomized controlled trials.
    Uson Junior PLS; Dias E Silva D; de Castro NM; da Silva Victor E; Rother ET; Araújo SEA; Borad MJ; Moura F
    ESMO Open; 2023 Feb; 8(1):100771. PubMed ID: 36638709
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Preoperative chemotherapy, radiotherapy and surgical decision-making in patients with borderline resectable and locally advanced pancreatic cancer.
    Stoop TF; Theijse RT; Seelen LWF; Groot Koerkamp B; van Eijck CHJ; Wolfgang CL; van Tienhoven G; van Santvoort HC; Molenaar IQ; Wilmink JW; Del Chiaro M; Katz MHG; Hackert T; Besselink MG;
    Nat Rev Gastroenterol Hepatol; 2024 Feb; 21(2):101-124. PubMed ID: 38036745
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Resection of Borderline Resectable and Locally Advanced Pancreatic Adenocarcinomas after Neoadjuvant Chemotherapy.
    Addeo P; Rosso E; Fuchshuber P; Oussoultzoglou E; De Blasi V; Simone G; Belletier C; Dufour P; Bachellier P
    Oncology; 2015; 89(1):37-46. PubMed ID: 25766660
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Adjuvant therapy for pancreas cancer: advances and controversies.
    Mulcahy MF
    Semin Oncol; 2007 Aug; 34(4):321-6. PubMed ID: 17674960
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Adjuvant gemcitabine versus NEOadjuvant gemcitabine/oxaliplatin plus adjuvant gemcitabine in resectable pancreatic cancer: a randomized multicenter phase III study (NEOPAC study).
    Heinrich S; Pestalozzi B; Lesurtel M; Berrevoet F; Laurent S; Delpero JR; Raoul JL; Bachellier P; Dufour P; Moehler M; Weber A; Lang H; Rogiers X; Clavien PA
    BMC Cancer; 2011 Aug; 11():346. PubMed ID: 21831266
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.